Recently, He has oriented his research toward establishing neural features associated with consciousness. he is leading a multimodal PET/fMRI study of brain mechanisms associated with the serotonin psychedelic psilocybin, to better understand how this promising and broadly applicable therapeutic affects the brain. He is collaborating with neurologists at Rigshospitalet including a project evaluating fMRI measures in coma patients to identify neural markers of conscious awareness and recovery.
She received her Doctor of Medicine Degree from George Washington University in 2002. She then completed 3 years of a General Surgical Categorical residency at Brown University/Rhode Island Hospital. From 2005 to 2006, she completed a Cutaneous Oncology Fellowship at the University of California, San Francisco. She then completed a Dermatology residency and an additional year of dermatologic research graduating in 2010 from the University of California, Irvine. After their Dermatology residency, she completed a Mohs Micrographic Surgery Fellowship at St. John’s Institute of Dermatology, London, the UK in 2011.
His main interests are in epidemiology and genetics, in particular in psoriasis and skin cancer including primary cutaneous lymphomas. He works and publishes general systems for epidemiologic methodology and classification of skin diseases. He is a member of several scientific societies and editorial boards, a member of the board of the German Dermato-Oncology Group (DeCOG), and co-chair of the Topic Advisory Group for the ICD-11 dermatology classification at the World Health Organization.
This section has yet to be updated by the user.